Table 2:
Cross-validation results
| Antibiotic | Lasso | Cluster-lasso | ||||||
|---|---|---|---|---|---|---|---|---|
| bACC | AUC | Support | Unitigs | bACC | AUC | Support | Unitigs | |
| Amikacin | 92.7 | 95.4 | 16 | 22 (4) | 92.3 | 95.7 | 11 | 93 (36) |
| Aztreonam | 76.7 | 81.9 | 31 | 45 (3) | 76.9 | 82.3 | 28 | 425 (125) |
| Cefepime | 74.0 | 80.4 | 53 | 65 (3) | 73.6 | 79.8 | 34 | 385 (111) |
| Cefoxitin | 82.4 | 88.7 | 134 | 155 (5) | 82.2 | 88.6 | 171 | 1,052 (221) |
| Ceftazidime | 91.6 | 95.8 | 51 | 69 (5) | 90.7 | 95.3 | 43 | 863 (185) |
| Ciprofloxacin | 95.6 | 98.6 | 25 | 27 (2) | 95.5 | 98.6 | 35 | 422 (139) |
| Imipenem | 93.1 | 93.6 | 10 | 10 (1) | 92.7 | 93.4 | 7 | 241 (194) |
| Meropenem | 91.7 | 94.0 | 8 | 8 (1) | 91.4 | 93.5 | 3 | 164 (159) |
| Piperacillin/tazobactam | 81.6 | 89.6 | 127 | 144 (4) | 81.5 | 89.0 | 120 | 1,220 (226) |
| Tetracycline | 83.0 | 88.5 | 181 | 198 (3) | 82.9 | 87.7 | 109 | 640 (104) |
This table summarizes the cross-validation results obtained by the lasso and cluster-lasso strategies for the 10 antibiotics, in terms of balanced accuracy (bACC), AUC, support size, overall number of unitigs involved, and maximal number of unitigs associated with a single pattern or cluster (in parentheses).